These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 3901741)

  • 41. Analysis of digoxin concentrations in serum by fluorescence polarization immunoassay: an evaluation.
    Ferreri LF; Raisys VA; Opheim KE
    J Anal Toxicol; 1984; 8(3):138-40. PubMed ID: 6376949
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of digoxin Fab antibodies on five digoxin immunoassays.
    Ujhelyi MR; Cummings DM; Green P; Ellison MJ; Vlasses PH
    Ther Drug Monit; 1990 May; 12(3):288-92. PubMed ID: 2349615
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Endogenous and exogenous digoxin-like immunoreactive substances: impact on therapeutic drug monitoring of digoxin.
    Dasgupta A
    Am J Clin Pathol; 2002 Jul; 118(1):132-40. PubMed ID: 12109847
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of the fluorescence polarization immunoassay for quantitation of digoxin in serum.
    Al-Fares AM; Mira SA; el-Sayed YM
    Ther Drug Monit; 1984; 6(4):454-7. PubMed ID: 6515706
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Demonstration of the presence of digoxin-like immunoreactive substance (DLIS) in the serum and urine in children with nephrotic syndrome.
    Shimabukuro N; Ebara H; Maruyama K; Tomizawa S; Kuroume T
    Clin Nephrol; 1988 May; 29(5):244-7. PubMed ID: 2840225
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Digoxin-like immunoreactive substance in renal failure: a reappraisal.
    Greenway DC; Nanji AA
    Nephron; 1986; 44(2):108-10. PubMed ID: 3774074
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Change of serum endogenous digitalis-like substance undergoing cardiopulmonary bypass].
    Luo T; Rui J; Li XJ; Zhang L; Zhang ZG; Qiu T; Yuan W; Luo Y; Fang B
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Mar; 39(2):272-5. PubMed ID: 18630701
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of endogenous digoxin-like substances on the interpretation of high concentrations of digoxin in children.
    Stone J; Bentur Y; Zalstein E; Soldin S; Giesbrecht E; Koren G
    J Pediatr; 1990 Aug; 117(2 Pt 1):321-5. PubMed ID: 2166153
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Is the volume of distribution of digoxin reduced in patients with renal dysfunction? Determining digoxin pharmacokinetics by fluorescence polarization immunoassay.
    Cheng JW; Charland SL; Shaw LM; Kobrin S; Goldfarb S; Stanek EJ; Spinler SA
    Pharmacotherapy; 1997; 17(3):584-90. PubMed ID: 9165563
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Endogenous cardiac glycoside-like substances in newborns, adults, pregnant women and patients with hypertension or renal insufficiency.
    Clerico A; Balzan S; Del Chicca MG; Paci A; Cocci F; Bertelli A
    Drugs Exp Clin Res; 1988; 14(9):603-7. PubMed ID: 3229323
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Factors of importance for valid digitalis assays particularly for the determination of digoxin in plasma and urine.
    Molin L
    Acta Pharmacol Toxicol (Copenh); 1986; 59 Suppl 4():1-62. PubMed ID: 3739734
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Digoxin-like immunoreactive substance in postmortem blood of infants and children.
    Spiehler VR; Fischer WR; Richards RG
    J Forensic Sci; 1985 Jan; 30(1):86-91. PubMed ID: 3981124
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Digoxin-like factor in infants of diabetic mothers not receiving digoxin therapy.
    Yurdakök M; Oran O; Tekinalp G; Göktoğan S
    Turk J Pediatr; 1989; 31(4):271-3. PubMed ID: 2486426
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Discordant results from "real-world" patient samples assayed for digoxin.
    Jones TE; Morris RG
    Ann Pharmacother; 2008 Dec; 42(12):1797-803. PubMed ID: 19033482
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Estimating concentrations of serum total digoxin and digoxin-like immunoreactive substances in patients of cardiac failure with renal insufficiency].
    Li JH; Wu ZG; Xu JQ; Zhou Y
    Yao Xue Xue Bao; 1997; 32(3):174-7. PubMed ID: 11327016
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Positive and negative interference of the Chinese medicine Chan Su in serum digoxin measurement. Elimination of interference by using a monoclonal chemiluminescent digoxin assay or monitoring free digoxin concentration.
    Dasgupta A; Biddle DA; Wells A; Datta P
    Am J Clin Pathol; 2000 Aug; 114(2):174-9. PubMed ID: 10941331
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Disposable-column radioimmunoassay for serum digoxin with less interference from metabolites and endogenous digitalis-like factors.
    Longerich L; Vasdev S; Johnson E; Gault MH
    Clin Chem; 1988 Nov; 34(11):2211-6. PubMed ID: 2846204
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Perinatal changes in a digoxin-like immunoreactive substance.
    Seccombe DW; Pudek MR; Whitfield MF; Jacobson BE; Wittmann BK; King JF
    Pediatr Res; 1984 Nov; 18(11):1097-9. PubMed ID: 6514436
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of microparticle enzyme and fluorescence polarization immunoassays in pediatric patients not receiving digoxin.
    Chicella M; Branim B; Lee KR; Phelps SJ
    Ther Drug Monit; 1998 Jun; 20(3):347-51. PubMed ID: 9631935
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Determination of blood digoxin].
    Janssen K
    Dtsch Med Wochenschr; 1990 Aug; 115(33):1254. PubMed ID: 2201511
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.